Key Insights into the Clinical Diagnostic Laboratory Market

The global clinical diagnostics industry is entering a phase of intelligent renewal. Clearstate’s CDx LabPro 2025 Survey shows laboratories across APAC and Europe shifting from rapid infrastructure growth to strategic modernization, with a focus on automation, digital integration, and lifecycle optimization. Clinical chemistry and immunoassay remain the backbone of routine testing, while molecular diagnostics is increasingly integrated into daily workflows. Clearstate’s latest report unpacks these trends, offering actionable insights for MedTech leaders to build smarter, more connected laboratories and guide strategic decisions.

Download

scientist-woman-sitting-laboratory-with-chemical-technology

From Expansion to Optimization

Laboratories are moving beyond volume-driven growth to intelligence-led operations, prioritizing efficiency, automation, and seamless data connectivity.

Core Testing Dominance

Clinical Chemistry and Immunoassay continue to anchor global test volumes, forming the backbone of routine diagnostics.

Molecular Integration Rising

PCR and “sample-to-answer” molecular systems are increasingly embedded in core labs, streamlining workflows and accelerating convergence.

Analyzer Market Consolidation

Roche, Abbott, and Siemens lead the instrument landscape, shaping global performance benchmarks and procurement trends.

Renewal Cycle Opportunity

With most labs entering a 6–9 year equipment replacement phase, a new investment cycle is emerging—unlocking strategic opportunities for MedTech partners to drive modernization and service-led growth.